Vaxart
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Vaxart and buy or sell other stocks, ETFs, and their options commission-free!About VXRT
Vaxart, Inc. is a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology (VAAST) oral vaccine platform. It is developing prophylactic vaccine candidates that target a range of infectious diseases, including SARS-CoV-2, norovirus, seasonal influenza and respiratory syncytial virus (RSV).
CEOSteven Lo
CEOSteven Lo
Employees115
Employees115
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2004
Founded2004
Employees115
Employees115
VXRT Key Statistics
Market cap190.86M
Market cap190.86M
Price-Earnings ratio-3.58
Price-Earnings ratio-3.58
Dividend yield—
Dividend yield—
Average volume597.40K
Average volume597.40K
High today$0.8185
High today$0.8185
Low today$0.7498
Low today$0.7498
Open price$0.76
Open price$0.76
Volume1.02M
Volume1.02M
52 Week high$0.8449
52 Week high$0.8449
52 Week low$0.2606
52 Week low$0.2606
Stock Snapshot
The current Vaxart(VXRT) stock price is $0.80, with a market capitalization of 190.86M. The stock trades at a price-to-earnings (P/E) ratio of -3.58.
On 2026-03-01, Vaxart(VXRT) stock moved within a range of $0.75 to $0.82. With shares now at $0.80, the stock is trading +6.0% above its intraday low and -2.9% below the session's peak.
Trading activity shows a volume of 1.02M, compared to an average daily volume of 597.4K.
The stock's 52-week range extends from a low of $0.26 to a high of $0.84.
The stock's 52-week range extends from a low of $0.26 to a high of $0.84.
People also own
Based on the portfolios of people who own VXRT. This list is generated using Robinhood data, and it’s not a recommendation.